Skip to content
healthcare.dev

Praluent

NDC 0024-5901, alirocumab, injection, solution, from Sanofi-Aventis U.S. LLC.

Product NDC
0024-5901
Status
Listed
Labeler
Sanofi-Aventis U.S. LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125559
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5901 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALIROCUMAB75 mg/mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; PCSK9 Inhibitor [EPC]; PCSK9 Inhibitors [MoA]

Package NDCNDC-11Package
0024-5901-00000245901001 SYRINGE, GLASS in 1 CARTON (0024-5901-00) / 1 mL in 1 SYRINGE, GLASS
0024-5901-01000245901011 SYRINGE, GLASS in 1 CARTON (0024-5901-01) / 1 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4

Use it

Look up 0024-5901 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5901 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0024-5901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.